Valneva SE (VALN) Change in Cash (2021 - 2026)
Valneva SE's (VALN) quarterly Change in Cash came in at -$5.5 million in Q1 2026, up 64.19% year-on-year from -$3.4 million in Q1 2025, and up 86.07% quarter-over-quarter from -$39.7 million in Q4 2025.
Valneva SE (VALN) Change in Cash (2021 - 2026) Analysis & Trends
Valneva SE has disclosed Change in Cash across 6 years of filings, most recently posting -$5.5 million for Q1 2026.
- Change in Cash for Q1 2026 came in at -$5.5 million, up 64.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$53.2 million (down 102.76% YoY), and the FY2025 annual result was -$64.3 million, down 248.98% from the prior year.
- Change in Cash came in at -$5.5 million for Q1 2026 at Valneva SE, up from -$39.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $88.6 billion in Q3 2023 to a low of -$88.8 billion in Q2 2023.
- The 5-year median for Change in Cash is -$15.5 million (2025), against an average of -$16.9 million.
- Peak annual rise in Change in Cash reached 111167.64% in 2023, while the deepest fall reached 345235.54% in 2023.
- Valneva SE's Change in Cash stood at $31.7 million in 2022, then sank by 253.64% to -$48.7 million in 2023, then surged by 121.11% to $10.3 million in 2024, then tumbled by 486.41% to -$39.7 million in 2025, then soared by 86.07% to -$5.5 million in 2026.
- The last three Change in Cash figures came in at -$5.5 million (Q1 2026), -$39.7 million (Q4 2025), and -$20.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -45.97 Mn |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -5.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.53 Mn |
| Dec 31, 2025 | -39.73 Mn |
| Sep 30, 2025 | -20.81 Mn |
| Jun 30, 2025 | 12.91 Mn |
| Mar 31, 2025 | -15.45 Mn |
| Dec 31, 2024 | 10.28 Mn |
| Sep 30, 2024 | 28.55 Mn |
| Jun 30, 2024 | -49.61 Mn |
| Mar 31, 2024 | 55.21 Mn |
| Dec 31, 2023 | -48.72 Mn |
| Sep 30, 2023 | 88.64 Bn |
| Jun 30, 2023 | -88.76 Bn |
| Mar 31, 2023 | -34.03 Mn |
| Dec 31, 2022 | 31.71 Mn |
| Sep 30, 2022 | -79.80 Mn |
| Jun 30, 2022 | 25.72 Mn |
| Mar 31, 2022 | -39.64 Mn |
| Dec 31, 2021 | 111.05 Mn |
| Sep 30, 2021 | -96.55 Mn |
| Jun 30, 2021 | 113.12 Mn |